Thermo Fisher Scientific

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$12,215,000
$11,122,000
$10,855,000
$10,364,000
Gross Profit
4,636,000
4,652,000
4,048,000
4,245,000
EBITDA
3,215,000
2,838,000
2,798,000
2,628,000
EBIT
2,488,000
2,175,000
2,113,000
1,923,000
Net Income
1,975,000
1,616,000
1,617,000
1,507,000
Net Change In Cash
12,215,000
11,122,000
10,855,000
10,364,000
Free Cash Flow
2,992,000
1,835,000
1,105,000
361,000
Cash
9,857,000
1,982,000
4,579,000
4,134,000
Basic Shares
377,000
378,000
378,000
379,000

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$44,556,000
$42,879,000
$42,857,000
$44,915,000
Gross Profit
16,778,000
17,728,000
17,562,000
19,011,000
EBITDA
11,466,000
11,800,000
6,859,000
11,942,000
EBIT
8,686,000
8,692,000
6,859,000
8,561,000
Net Income
6,737,000
6,335,000
5,995,000
6,950,000
Net Change In Cash
44,556,000
42,879,000
42,857,000
44,915,000
Cost of Revenue
4,185,000
Free Cash Flow
6,293,000
7,267,000
6,927,000
6,911,000
Cash
9,857,000
4,009,000
8,083,000
8,524,000
Basic Shares
377,000
383,000
388,000
394,000

Earnings Calls

QuarterEPS
2026-03-31
$0
2025-12-31
$6.57
2025-09-30
$5.79
2025-06-30
$5.36